BETA

Activities of Eleni THEOCHAROUS related to 2016/2057(INI)

Shadow opinions (1)

OPINION on EU options for improving access to medicines
2016/11/22
Committee: DEVE
Dossiers: 2016/2057(INI)
Documents: PDF(127 KB) DOC(64 KB)

Amendments (6)

Amendment 5 #
Draft opinion
Paragraph 1
1. Recalls that Sustainable Development Goal 3, with nine quantitative and four qualitative targets, clearly states that by 2030 everyone should have access to good mental and physical health throughout their lives; underlines that, each year, 100 million people fall into poverty because of health costs which are disproportionate to their incomes, and that, according to the WHO, over one third of the world’s population, with over 50 % in Africa, does not have access to medicines; due to inequalities such as lower education levels, lower incomes and due to limited access to information, limited infrastructure and limited reachability of point of access in rural areas along with lack of diagnosis;
2016/09/09
Committee: DEVE
Amendment 16 #
Draft opinion
Paragraph 1 a (new)
1a. Recalls that the aim should be reaching people who need health care, when and where they need it while acknowledging that availability of medicines, as well as all the elements of health care systems, are subject to conflicts and emergencies, in which case emergency response systems are deemed necessary to effectively prevent and/or respond to a possible outbreak;
2016/09/09
Committee: DEVE
Amendment 19 #
Draft opinion
Paragraph 1 b (new)
1b. Stresses that building strong surveillance and delivery systems at all levels, from community to district, provincial and national levels supported by high quality laboratory services and strong logistical systems could make access to medicines more feasible; while the transfer of health-related technologies (through licence agreements, provision of information, know-how and performance skills, to technical materials and equipment) to developing countries can enable recipient countries to produce the product locally and may result in increased access to the product and improved health;
2016/09/09
Committee: DEVE
Amendment 60 #
Draft opinion
Paragraph 4 a (new)
4a. Stresses the need to invest in Research and Development (R&D) with regards to Poverty-related and Neglected Diseases (PRND) in order to achieve affordable, safe and effective medicines and vaccines for all;
2016/09/09
Committee: DEVE
Amendment 63 #
Draft opinion
Paragraph 4 b (new)
4b. Urges towards contributing financially to global initiatives, such as the WHO Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property that aim at alleviating the access problem through the supply of medicines or capacity building as well as with multi-funder initiatives;
2016/09/09
Committee: DEVE
Amendment 81 #
Draft opinion
Paragraph 5 a (new)
5a. Urges the Commission, as a member of boards of global health organisations that address access to medicines and vaccines, such as WHO, The Global Fund, UNFPA, to actively support their initiatives and to aid in promoting and driving the policy agendas towards that direction;
2016/09/09
Committee: DEVE